Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Haematologica|August 22, 2015
Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferationEleonora Fonte, Andreas Agathangelidis, Daniele Reverberi, et al.
Hematological Oncology|March 8, 2018
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleedingGiuseppe Boriani, Paolo Corradini, Antonio Cuneo, et al.
British Journal of Haematology|December 22, 2015
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective studyJorge J Castillo, Shirley D'Sa, Michael P Lunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2025
Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/<i>TP53</i> Mutation: SEQUOIA Arm D ResultsMazyar Shadman, Talha Munir, Shuo Ma, et al.
American Journal of Hematology|March 16, 2017
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphomaFrancesca Romana Mauro, Piero Galieni, Alessandra Tedeschi, et al.
Blood|July 23, 2020
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-upJudith Trotman, Stephen Opat, David Gottlieb, et al.
Seminars in Hematology|May 12, 2023
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteriaSteven P Treon, Alessandra Tedeschi, Jesus San-Miguel, et al.
American Journal of Hematology|September 29, 2011
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experienceLuca Laurenti, Michela Tarnani, Ilaria Nichele, et al.
Pageof 17